Intensivmedizinisches Management schwerer Infektionen bei Krebspatienten

Abstract

Despite treatment options of cancer patients have been improved, the treatment of complications is usually very complex and often includes intensive care unit admission. Infections play a major role here. Risk patients and factors, timely detection of infections and septic states, diagnostic options and treatment options in the management of these cancer patients will be presented in this paper.

Infektionen tragen wesentlich zu Morbidität und Mortalität hämatoonkologischer Patienten bei und gehören zu den Hauptgründen für die Aufnahme auf die Intensivstation. Hier ist in besonderem Maße die Kooperation von Intensivmedizinern, Onkologen, Infektiologen, ggf. Chirurgen und anderen Disziplinen erforderlich. Der Beitrag stellt die bestehenden Risiken und das intensivmedizinische Management bei diesen Patienten vor.

Schlüsselwörter

Krebs - Intensivstation - Hämatologie - Onkologie - Infektion - Sepsis

Key words

cancer - Intensive Care Unit - hematology - oncology - infection - sepsis

• Literatur

• 1 Kochanek M, Schalk E, von Bergwelt-Baildon M. et al. Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 2019; 98: 1051-1069
• 2 Hillmen P, Robak T, Janssens A. et al. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial. Lancet 2015; 385: 1873-1883
• 3 Aksoy S, Dizdar Ö, Hayran M. et al. Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis. Leukemia & Lymphoma 2009; 50: 357-365
• 4 Rhodes A, Evans LE, Alhazzani W. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017; 43: 304-377
• 5 Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med 2018; 44: 925-928
• 6 Singer M, Deutschman CS, Seymour CW. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-810
• 7 Maschmeyer G, Carratala J, Buchheidt D. et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 2015; 26: 21-33
• 8 Gudiol C, Royo-Cebrecos C, Laporte J. et al. Clinical features, aetiology and outcome of bacteraemic pneumonia in neutropenic cancer patients. Respirology 2016; 21: 1411-1418
• 9 Sandherr M, Hentrich M, von Lilienfeld-Toal M. et al. Antiviral prophylaxis in patients with solid tumours and haematological malignancies-update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Hematol 2015; 94: 1441-1450
• 10 von Lilienfeld-Toal M, Berger A, Christopeit M. et al. Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. Eur J Cancer 2016; 67: 200-212
• 11 Valentine JC, Morrissey CO, Tacey MA. et al. A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005–2016. BMC Infect Dis 2019; 19: 274
• 12 Taccone FS, Van den Abeele AM, Bulpa P. et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care 2015; 19: 7
• 13 Azoulay E, Pickkers P, Soares M. et al. Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med 2017; 43: 1808-1819
• 14 Gerritsen MG, Willemink MJ, Pompe E. et al. Improving early diagnosis of pulmonary infections in patients with febrile neutropenia using low-dose chest computed tomography. PLoS ONE 2017; 12: e0172256
• 15 Wohlfarth P, Turki AT, Steinmann J. et al. Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays. Biol Blood Marrow Transplant 2018; 24: 1707-1714
• 16 Boch T, Spiess B, Cornely OA. et al. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study. Clin Microbiol Infect 2016; 22: 862-868
• 17 Ruhnke M, Behre G, Buchheidt D. et al. Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO). Mycoses 2018; 61: 796-813
• 18 Ullmann AJ, Aguado JM, Arikan-Akdagli S. et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 2018; 24 (Suppl. 01) e1-e38
• 19 Schmidt-Hieber M, Bierwirth J, Buchheidt D. et al. Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 2018; 97: 31-49
• 20 Sengar M, Kelkar R, Jain H. et al. Frequency of bacterial isolates and pattern of antimicrobial resistance in patients with hematological malignancies: A snapshot from tertiary cancer center. Indian J Cancer 2014; 51: 456-458